Literature DB >> 19625583

Adequacy of testing, empiric treatment, and referral for adult male emergency department patients with possible chlamydia and/or gonorrhoea urethritis.

R C Merchant1, D M Depalo, M D Stein, J D Rich.   

Abstract

This study evaluated the adequacy of testing, empiric treatment and referral for further evaluation of adult male emergency department (ED) patients with possible chlamydia and/or gonorrhoea urethritis. Of 968 adult male ED patients, 84% were tested for chlamydia and gonorrhoea, 16% for HIV and 27% for syphilis; 92% received empiric treatment for chlamydia and gonorrhoea and 71% were referred for further evaluation; of those tested, 29% were infected with chlamydia, gonorrhoea or both; and 3% of those tested had a positive syphilis test. The results of logistic regression modelling indicated that testing, treatment and referral were not related to a history of sexual contact with someone known to have a sexually transmitted disease or to the patient's ultimate diagnosis of a laboratory-confirmed infection. Compliance with Centers for Disease Control and Prevention (CDC) recommendations for chlamydia and gonorrhoea testing and treatment regimens was high, but was poor for HIV testing. More explicit guidance from CDC regarding syphilis testing and referral for further evaluation is needed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19625583      PMCID: PMC2936231          DOI: 10.1258/ijsa.2008.008395

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  14 in total

1.  Gender differences in testing for syphilis in emergency department patients diagnosed with sexually transmitted diseases.

Authors:  M Garfinkel; H Blumstein
Journal:  J Emerg Med       Date:  1999 Nov-Dec       Impact factor: 1.484

2.  Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.

Authors:  Bernard M Branson; H Hunter Handsfield; Margaret A Lampe; Robert S Janssen; Allan W Taylor; Sheryl B Lyss; Jill E Clark
Journal:  MMWR Recomm Rep       Date:  2006-09-22

3.  Emergency department screening for syphilis in patients with other suspected sexually transmitted diseases.

Authors:  A A Ernst; J D Samuels; D K Winsemius
Journal:  Ann Emerg Med       Date:  1991-06       Impact factor: 5.721

4.  Emergency department screening for syphilis in pregnant women without prenatal care.

Authors:  A A Ernst; R Romolo; T Nick
Journal:  Ann Emerg Med       Date:  1993-05       Impact factor: 5.721

5.  Screening and empiric treatment for syphilis in an inner-city emergency department.

Authors:  A A Ernst; T A Farley; D H Martin
Journal:  Acad Emerg Med       Date:  1995-09       Impact factor: 3.451

6.  1993 sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1993-09-24

7.  Syphilis screening in out-of-hospital care.

Authors:  E Marvez-Valls; S J Weiss; A A Ernst; W D Johnson
Journal:  Am J Emerg Med       Date:  1995-07       Impact factor: 2.469

8.  Compliance with the Centers for Disease Control and Prevention recommendations for the diagnosis and treatment of sexually transmitted diseases.

Authors:  Bryan G Kane; Linda C Degutis; Helen K Sayward; Gail D'Onofrio
Journal:  Acad Emerg Med       Date:  2004-04       Impact factor: 3.451

9.  Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2002-05-10

10.  High syphilis rates among cocaine abusers identified in an emergency department.

Authors:  A A Ernst; D H Martin
Journal:  Sex Transm Dis       Date:  1993 Mar-Apr       Impact factor: 2.830

View more
  2 in total

1.  Missed opportunities for concurrent HIV-STD testing in an academic emergency department.

Authors:  Pamela W Klein; Ian B K Martin; Evelyn B Quinlivan; Cynthia L Gay; Peter A Leone
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

2.  Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis.

Authors:  Ronald N Jones; Douglas J Biedenbach; Patricia M Roblin; Stephan A Kohlhoff; Margaret R Hammerschlag
Journal:  Antimicrob Agents Chemother       Date:  2010-07-26       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.